A record of what Riyank Arora said publicly, with the source. Not advice.
“Bullish on Piramal Pharma for the short term, recommending a buy at CMP ₹232 with a target of ₹250 and a stop-loss at ₹220. The stock exhibits bullish momentum with strong buying interest around ₹220 and improving RSI, suggesting potential for further gains if it breaks above ₹250.”
Riyank Arora’s track record (trackable calls only): 124 graded calls · 95% CI 23–39%
How this call is judged
A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate.
Entry: ₹232, as stated.
Target ₹250, stop ₹220, as stated.
Window: 30 days, from the call's own horizon word ("for the short term").
Waiting for a close to reach the entry.
This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.